Polycaprolactone-bioactive glass hybrids as a controlled release platform for the delivery of therapeutics in bone tissue engineering. - Université Clermont Auvergne Accéder directement au contenu
Communication Dans Un Congrès Année : 2021

Polycaprolactone-bioactive glass hybrids as a controlled release platform for the delivery of therapeutics in bone tissue engineering.

Fichier non déposé

Dates et versions

hal-03549046 , version 1 (31-01-2022)

Identifiants

  • HAL Id : hal-03549046 , version 1

Citer

Lukas Gritsch, Cédric Bossard, Christiane Forestier, Edouard Jallot, Henri Granel, et al.. Polycaprolactone-bioactive glass hybrids as a controlled release platform for the delivery of therapeutics in bone tissue engineering.. ESB 2021, 31th Conference of the European Society for Biomaterials, Sep 2021, Porto, Portugal. ⟨hal-03549046⟩
47 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More